Condition
Foot Ulcer Due to Type 2 Diabetes Mellitus clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Foot Ulcer Due to Type 2 Diabetes Mellitus clinical trials that are recruiting, at sites in 4 countries (most in United States (2), Brazil (1), Denmark (1)). By phase: Phase 4 (2), Phase 3 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest Foot Ulcer Due to Type 2 Diabetes Mellitus clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients | — | Bragança Paulista, São Paulo | Recruiting | Sep 3, 2026 |
| Semaglutide to help heal foot ulcers in people with type 2 diabetes | Phase 3 | Copenhagen | Recruiting | May 12, 2026 |
| Single-layer placental graft plus standard care for stubborn diabetic foot ulcers | Phase 4 | Hollywood, Florida | Recruiting | Sep 8, 2025 |
| Wound matrix treatments for nonhealing diabetic foot ulcers | Phase 4 | Monroeville, Pennsylvania | Recruiting | Jul 25, 2025 |
| Using stem cells from fat to treat diabetic foot ulcers | Phase 1 | Lahore, Punjab Province | Recruiting | Nov 9, 2022 |
All recruiting trials (5)
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
Semaglutide to help heal foot ulcers in people with type 2 diabetes
This 20-week randomized, double-blind trial will try semaglutide versus placebo to see if it helps heal foot ulcers in adults with type 2 diabetes.
-
Single-layer placental graft plus standard care for stubborn diabetic foot ulcers
This trial will try a single-layer placental-based graft together with usual wound care for adults whose diabetic foot ulcers did not heal after standard treatment in an earlier trial.
-
Wound matrix treatments for nonhealing diabetic foot ulcers
This trial will test whether adding special wound matrix products to standard care helps close hard-to-heal diabetic foot ulcers in adults with type 1 or 2 diabetes within 12 weeks.
-
Using stem cells from fat to treat diabetic foot ulcers
This study is testing if using stem cells from fat, along with a special blood product, can help heal chronic foot ulcers in people with diabetes.
Related topics
Quick answers
How many Foot Ulcer Due to Type 2 Diabetes Mellitus clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Brazil (1 trial), Denmark (1 trial), Pakistan (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 3: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.